Application of N-acetylglucosamine as marker in preparation of reagent for diagnosing ischemic cerebral apoplexy

An acetylglucosamine and ischemic stroke technology, applied in the field of medical diagnosis, can solve problems such as the influence of metal implants on examination, and achieve the effects of reducing the volume of cerebral infarction, high accuracy and specificity, and improving the therapeutic effect

Active Publication Date: 2021-10-01
CHINA PHARM UNIV
View PDF8 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, other diseases such as migraine and seizures are similar to the clinical symptoms of stroke. Although brain imaging is a relatively direct way to diagnose stroke, it also has certain limitations, such as metal implants or restlessness in some patients. will affect the inspection

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of N-acetylglucosamine as marker in preparation of reagent for diagnosing ischemic cerebral apoplexy
  • Application of N-acetylglucosamine as marker in preparation of reagent for diagnosing ischemic cerebral apoplexy
  • Application of N-acetylglucosamine as marker in preparation of reagent for diagnosing ischemic cerebral apoplexy

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0035] Targeted Metabolomics Validation:

[0036] 1. Preparation of middle cerebral artery occlusion / reperfusion (MCAO / R) mouse model

[0037] Mice were intraperitoneally injected with 1% sodium pentobarbital, anesthetized, fixed in the supine position, and incised in the midline of the neck. The right common carotid artery, external carotid artery and internal carotid artery were separated and exposed, a ligature was reserved at the proximal end of the common carotid artery, the external carotid artery was ligated at the distal end, and the distal end of the external carotid artery was freed. A section of the internal carotid artery was freed along the internal carotid artery to the deep part, and a ligature was reserved at the proximal end of the external carotid artery. The common carotid artery at the proximal end and the internal carotid artery at the distal end were clamped with a small non-invasive vascular clip, and a small opening was cut with micro scissors at the d...

Embodiment 2

[0053] Metabolite functional verification:

[0054] 1. TTC staining

[0055] After modeling MCAO / R, the brain tissue of each group of mice was taken out, placed in a -70°C refrigerator until the brain tissue was completely frozen, taken out on the ice box, and the frozen brain tissue was cut into 5 coronal brain slices with a thickness of about 2 mm. , quickly put the cut brain slices into the 2% TTC solution, paying attention to placing the brain slices in one direction. Subsequently, incubate in a 37°C oven for 30 min in the dark. Placed on a black cardboard to take pictures and transferred to a computer, Image J image analysis software was used to measure the volume of cerebral infarction. Calculated as follows:

[0056] Percentage of infarct volume = right hemisphere infarction volume / total brain volume × 100%;

[0057] The larger the infarct volume, the more severe the stroke. Under normal circumstances, the volume of cerebral infarction caused by MCAO / R is 30%-40%; ...

Embodiment 3

[0065] Functional validation of metabolite-regulated enzymes

[0066] 1. Experimental reagents and equipment

[0067] N-acetylglucosamine kinase (NAGK) overexpressed adeno-associated virus (AAV-NAGK) and empty adenovirus (AAV-control) were provided by Shanghai Jiman Biotechnology Co., Ltd. and tested: GPAAV-CMV-M_Nagk-EF1- The titer of ZsGreen1-WPRE was 1.21E+13VG / mL; microsyringe (1 μL); brain localizer (Stoelting, USA).

[0068] 2. Synthetic primers

[0069] carrier information such as figure 1 ; Design PCR amplification fragment primers, and introduce the homologous sequence at the end of the linearized cloning vector at the 5' end of the primer, so that the 5' and 3' most end sequences of the amplification product are completely consistent with the sequences at both ends of the linearized cloning vector, respectively. The sequence is as follows:

[0070]

[0071] 3. In situ injection of adeno-associated virus into the brain

[0072] After the mice were anesthetized...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Titeraaaaaaaaaa
Login to View More

Abstract

The invention discloses application of N-acetyl glucosamine as a marker in preparation of a reagent for diagnosing ischemic cerebral apoplexy. According to the invention, differential expression of N-acetyl glucosamine in serum of ischemic cerebral apoplexy and non-ischemic cerebral apoplexy contrasts is shown, the N-acetyl glucosamine is taken as a marker to quantitatively detect the metabolic level in the serum, and meanwhile, the N-acetyl glucosamine can be combined with a regulatory enzyme N-acetyl glucosamine kinase to relieve brain injury. Therefore, the N-acetyl glucosamine metabolism level detection has a very high clinical application value in the diagnosis of the ischemic cerebral apoplexy, and a brand new way is provided for the rapid and effective diagnosis of the ischemic cerebral apoplexy.

Description

technical field [0001] The invention relates to the application of N-acetylglucosamine as a marker in the preparation of reagents for diagnosing ischemic cerebral apoplexy, belonging to the field of medical diagnosis. Background technique [0002] Stroke is a neurological deficit caused by acute focal damage to the central nervous system (ie, brain, retina, or spinal cord) caused by vascular causes, and can be roughly divided into two categories, ischemic and hemorrhagic stroke. Among them, ischemic stroke is ischemic infarction caused by arterial blockage, and is the main type of stroke. At present, thrombolytic therapy is the most effective method for the clinical treatment of acute ischemic stroke, but the treatment time window is extremely narrow and it is easy to cause cerebral ischemia-reperfusion injury, aggravating the degree of disease deterioration. Therefore, the timely diagnosis and effective treatment of ischemic stroke have attracted more and more attention fr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12Q1/48
CPCC12Q1/485G01N2800/2871
Inventor寇俊萍马慧芬李芳宫帅帅张媛媛余伯阳
OwnerCHINA PHARM UNIV